Jefferies Downgrades AcelRx Pharmaceuticals To Hold

Loading...
Loading...
Analysts at Jefferies downgraded
AcelRx Pharmaceuticals, Inc.ACRX
from Buy to Hold. The price target for AcelRx Pharmaceuticals has been lowered from $12.00 to $6.00. AcelRx Pharmaceuticals shares have dropped 53.70% over the past 52 weeks, while the S&P 500 index has surged 11.34% in the same period. AcelRx Pharmaceuticals' shares fell 0.91% to $5.46 in after-hours trading.
Market News and Data brought to you by Benzinga APIs
Posted In: DowngradesAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...